Marcin Caliński

Marcin Caliński

Auto-generated profile, based on publicly available information

Marcin Caliński

Section of Diabetology of the Student Scientific Association, Department of Endocrinology, Diabetology and Metabolic Diseases, Medical University of Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2025 in Medical Science Pulse
Verified
Journal Article
Closed access
HBHubert Marcin Bednarz
Hubert Marcin Bednarz
MCMarcin Caliński
Marcin Caliński
KSKlaudia Salamon
Klaudia Salamon
JGJoanna Góra
Joanna Góra
MGMichał Piotr Granat
Michał Piotr Granat
DPDominik Porada
Dominik Porada
Backgorund: Diabetes is one of the biggest public health problems of the current era. It develops numerous complications, which can be divided into macroangiopathies (ischemic heart disease, limb and cerebral vascular disease) and microangiopathies (retinopathy, nephropathy, neuropathy). They significantly limit patients' quality of life and survival. Therefore, it is extremely important to prevent and treat them early. For this reason, it is important to search for new biomarkers that will make this possible. The purpose of this paper is to search for such predictors using a systematic review method.Methods: A systematic review was conducted in online databases of full-text scientific papers from 2020-2025. 49 papers were included in the review.Results: Capillary blood glucose and HbA1c are adequate indicators of diabetes control, but have their limitations as predictors of distant complications in the disease. Among the best predictors are: fructosamine (nephropathy, macroangiopathy, postsurgica complications), interleukin 6 (microangiopathies), fetuin A (nephropathy, macroangiopathy), 1,5-anhydroglucitol (coronary heart disease), adiponectin (nephropathy, neuropathy), transferrin and ferritin (nephropathy, retinopathy), acylcarnitines (retinopathy, neuropathy), lipoprotein a and plasminogen activator inhibitor 1 (mainly macroangiopathies). Determination of their levels in blood or other biological materials can serve as a good predictor of the development of distant complications of diabetes, making it possible to identify patients at risk.Conclusions: There are good potential predictors (especially fructosamine) of distant diabetes complications other than glycemia and HbA1c. Their determination in the future may be incorporated into diagnostic protocols alone or in combination with older markers to identify at-risk patients and for effective prevention.

24 October 2025 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
PDF file
KBKarol Bigosiński
Karol Bigosiński
MGMichał Piotr Granat
Michał Piotr Granat
KSKlaudia Salamon
Klaudia Salamon
JGJoanna Góra
Joanna Góra
MCMarcin Caliński
Marcin Caliński
DPDominik Porada
Dominik Porada
The milestone – role of miRNAs as predictors of diabetes complications: a literature review. Diabetes mellitus (DM) is one of the biggest health problems of the 21st century. The complications of DM are macrovascular (ischemic di...